MASLD is characterized by pathological accumulation of triglycerides in hepatocytes occurring in the absence of significant alcohol consumption, driven primarily by insulin resistance-induced hepatic lipogenesis [2]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.